Related Experiment Videos
Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass
Anne K Callesen1, Shabaz Mohammed, Jakob Bunkenborg
1Protein Research Group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Rapid Communications in Mass Spectrometry : RCM
|May 26, 2005
Summary
A new serum profiling method using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) with solid-phase extraction (SPE) offers reproducible protein profiles for early disease diagnosis. This technique shows promise for clinical proteomics and identifying biomarkers for conditions like breast cancer.
Area of Science:
- Clinical Proteomics
- Analytical Chemistry
- Biomarker Discovery
Background:
- Serum profiling via MALDI-MS is crucial for early disease diagnosis.
- Reproducible sample preparation is essential for clinical MALDI-MS applications.
- Current methods require optimization for reliable serum protein analysis.
Purpose of the Study:
- To investigate MALDI matrices and miniaturized SPE for serum protein concentration and desalting.
- To develop a simple, reproducible protocol for serum profiling using MALDI-MS.
- To assess the potential of SPE/MALDI-MS for clinical proteomics.
Main Methods:
- Investigated various MALDI matrices and miniaturized SPE techniques.
- Developed a protocol combining a specific matrix mixture with SPE and MALDI-MS.
- Utilized functionalized membrane discs (hydrophobic, ion-exchange, chelating) for serum processing.
Main Results:
- Achieved reproducible MALDI mass spectra (m/z 1000-12,000) from serum using functionalized membrane discs.
- Demonstrated proof-of-principle by identifying protein peaks distinguishing breast cancer patients from controls.
- Validated the effectiveness of the combined SPE/MALDI-MS approach.
Conclusions:
- The developed SPE/MALDI-MS protocol provides a versatile and scalable platform for serum profiling.
- This method enhances reproducibility and signal quality for MALDI-MS clinical applications.
- The approach holds significant potential for early cancer diagnosis and clinical proteomics.